Indefinite Delivery Contract SPE2DX24D9950

The federal contract IDV award SPE2DX24D9950 is a single-award indefinite delivery contract (IDC) with a ceiling value of $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through December 31, 2025, is part of the DLA's Medical Supply Chain program and allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide.

Under this IDC, DMS Pharmaceutical Group provides a comprehensive array of medications, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The products supplied cover a diverse spectrum, from common medications like antibiotics and pain relievers to specialized drugs such as oncology treatments and specialty pharmaceuticals. This IDC complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) healthcare facilities, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.